Pairs well with20 on file
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Cobalamin and folate meet at methionine synthase, where a methyl group moves from methylfolate to homocysteine through a cobalamin cofactor. Folate given without adequate cobalamin leaves that cobalamin-dependent step short, which is why the two are paired.
Folate cannot leave its methylated form without a cobalamin-dependent methionine synthase step, so the two nutrients gate each other. Blends carry both so neither cycle stalls.
Cobalamin drives the remethylation of homocysteine back to methionine, and vitamin B6 drives the transsulfuration route that sends it on to cysteine. Covering both exits is standard in methylation formulas.
Betaine methylates homocysteine through betaine-homocysteine methyltransferase, a route that needs neither cobalamin nor folate. Pairing it with cobalamin gives the cycle a second lane when the cobalamin-dependent one is loaded.
Flavin cofactors reduce incoming cobalamin to the state its enzymes need, and FAD is the cofactor of methylenetetrahydrofolate reductase that makes methylfolate. Riboflavin status therefore shapes how usable a cobalamin dose is.
Biotin-dependent propionyl-CoA carboxylase makes methylmalonyl-CoA, and adenosylcobalamin-dependent methylmalonyl-CoA mutase converts it onward to succinyl-CoA. The two vitamins run back-to-back steps in the same route from odd-chain fats and several amino acids.
Methionine regenerated by the cobalamin-dependent step is what the body converts into SAM-e, and spent SAM-e returns as homocysteine for that same step. Supplying SAM-e directly loads the cycle downstream of where cobalamin acts.
Carnitine carries fatty acids into mitochondria, and adenosylcobalamin-dependent mutase clears the methylmalonyl-CoA generated when odd-chain fatty acids are oxidised there. The pair covers transport and downstream handling of the same fuel.
Iron supplies heme and cobalamin supports the DNA synthesis side of erythropoiesis, so a shortfall in either limits normal red cell production. Blood-support blends carry both because covering one leaves the other input limiting.
Homocysteine that is not remethylated by the cobalamin-dependent step is routed to cysteine and on to glutathione, and NAC feeds that same cysteine pool directly. The pairing loads both exits from one branch point.
High ascorbate concentrations destroy cobalamin in aqueous mixtures, an effect documented in liquid and powdered blends. Separating them in time, or using a dry dosage form, avoids losing the cobalamin dose.
Adenosylcobalamin is the cofactor for methylmalonyl-CoA mutase inside mitochondria; methylcobalamin is the cofactor for methionine synthase in the cytosol. Cells make both from whatever cobalamin arrives, so neither is a substitute for the other functionally, and a product carrying both simply supplies the two coenzyme forms directly. This is enzymology, not a comparison between products.
Methionine, along with valine, isoleucine and threonine, is catabolised to propionyl-CoA, carboxylated to methylmalonyl-CoA, and then requires adenosylcobalamin-dependent mutase to reach succinyl-CoA. Higher throughput of these amino acids raises demand for that single step. When the step is limited, methylmalonic acid accumulates, which is a marker of the enzyme's function rather than a clinical outcome.
Valine catabolism converges on methylmalonyl-CoA, so its final entry into the citric acid cycle depends on the adenosylcobalamin-requiring mutase. A diet or formula heavy in branched-chain amino acids increases traffic through that one cobalamin-dependent reaction. The relationship is a settled pathway, with no combination trial needed to state it.
Threonine is one of the four amino acids whose carbon skeleton reaches the citric acid cycle by way of propionyl-CoA and methylmalonyl-CoA. That route needs adenosylcobalamin at the mutase step. Listing it makes the demand side of B12 biochemistry visible on the page.
The cubilin receptor in the ileum binds the intrinsic factor and cobalamin complex in a calcium-dependent way, which is the textbook reason interference with that step lowers B12 uptake. Adequate calcium in the intestinal lumen is a requirement for that receptor step to work. This says nothing about extra calcium improving B12 status above normal.
Converting cobalamin to its adenosyl form uses ATP, and ATP-dependent enzymes work as magnesium complexes. Cells therefore need magnesium to maintain the pool of adenosylcobalamin they generate internally. No trial has measured B12 coenzyme status against magnesium intake, so the confidence sits below Established for the practical claim while the chemistry itself is settled.
When a deep B12 shortfall is corrected quickly, a wave of new cell formation moves potassium from plasma into cells and serum potassium can fall. This is a recognised monitoring point during rapid repletion and belongs to clinical supervision rather than to routine supplement use. It is listed as a caution about timing, not a recommendation to combine the two.
Adenosylcobalamin lets propionate-derived carbon enter the citric acid cycle as succinyl-CoA, while coenzyme Q10 carries electrons in the respiratory chain downstream of it. Both therefore touch mitochondrial ATP output at different points. No combination study exists, so this is a mechanism-level pairing marked page-only.
Colonic fermentation yields butyrate and propionate together, and propionate is handled through propionyl-CoA and methylmalonyl-CoA, the adenosylcobalamin-dependent step. Products delivering short-chain fatty acids or the fibres that generate them therefore add traffic to that node. The link is a settled pathway; nothing has measured coenzyme B12 turnover against short-chain fatty acid intake in people.